Concepedia

Publication | Closed Access

ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L

DOI

59

Citations

27

References

2016

Year

Ronghao Wang, Wanying Lin, Chang-Yi Lin, Lei Li, Yin Sun, Chawnshang Chang
Cancer Letters

References

YearCitations

Page 1